当前位置：
X-MOL 学术
›
Hum. Genomics
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
Human Genomics ( IF 4.5 ) Pub Date : 2020-06-05 , DOI: 10.1186/s40246-020-00268-2 Yanhui Liu 1 , Hailiang Liu 2 , Yi He 1 , Wanfang Xu 1 , Qiulin Ma 1 , Yuzhen He 3 , Wei Lei 2 , Guoquan Chen 3 , Zheng He 2 , Jiayi Huang 2 , Jianan Liu 4 , Yuanru Liu 2 , Quanfei Huang 2 , Fubing Yu 1
Human Genomics ( IF 4.5 ) Pub Date : 2020-06-05 , DOI: 10.1186/s40246-020-00268-2 Yanhui Liu 1 , Hailiang Liu 2 , Yi He 1 , Wanfang Xu 1 , Qiulin Ma 1 , Yuzhen He 3 , Wei Lei 2 , Guoquan Chen 3 , Zheng He 2 , Jiayi Huang 2 , Jianan Liu 4 , Yuanru Liu 2 , Quanfei Huang 2 , Fubing Yu 1
Affiliation
Cell-free fetal DNA (cffDNA) has opened up new approaches for non-invasive prenatal testing (NIPT), and it is often used as the second-tier test for high-risk pregnant women in detecting trisomy (T) 21, T18, and T13 after serum biochemistry screening. This study aims to discuss the clinical performance of NIPT as an alternative first-tier screening test for pregnant women in detecting T21, T18, T13, and sex chromosome aneuploidies (SCAs) in China. A total of 42,924 samples were recruited. The cell-free plasma DNA was directly sequenced. Each of the chromosome aneuploidies of PPV was analyzed. A total of 22 placental samples were acquired, including 14 FP and 8 TP samples. The placental verification of FP NIPT results was performed. Among 42,924 samples, 281 (0.65%) positive cases, including 87 of T21, 31 of T18, 22 of T13, and 141 of SCAs were detected. For the detection of T21, the positive predictive value (PPV) was 78.46%, for trisomy 18, 62.96%, for trisomy 13, 10.00%, for SCAs, 47.22% in the total samples. For trisomy 21, the PPV was 86.67%, for trisomy 18, 80.00%, for trisomy 13, 20.00%, for SCAs, 56.52% in advanced maternal age (AMA) women. The PPV of T21 increased with age. For T18, the PPV showed an overall upward trend. For T13 and SCAs, PPV was raised first and then lowered. Placental verification of false positive (FP) NIPT results confirmed confined placental mosaicism(CPM) was the reason for false positives. This study represents the first time that NIPT has been used as a first-tier screening test for fetal aneuploidies in a pilot city with large clinical samples in China. We propose that NIPT could replace serum biochemistry screening as a first-tier test.
更新日期：2020-06-05
京公网安备 11010802027423号